Acknowledgement
Supported by : NIH/NIAID
References
- Akira, S. (2006). TLR signaling. Curr. Top Microbiol. Immunol. 311, 1-16 https://doi.org/10.1007/3-540-32636-7_1
- Akira, S., Yamamoto, M., and Takeda, K. (2003). Role of adapters in Toll-like receptor signalling. Biochem. Soc. Trans. 31, 637-642 https://doi.org/10.1042/BST0310637
- Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801 https://doi.org/10.1016/j.cell.2006.02.015
- Alarcon, J.B., Hartley, A.W., Harvey, N.G., and Mikszta, J.A. (2007). Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin. Vaccine Immunol. 14, 375-381 https://doi.org/10.1128/CVI.00387-06
- Auewarakul, P., Kositanont, U., Sornsathapornkul, P., Tothong, P., Kanyok, R., and Thongcharoen, P. (2007). Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25, 659-663 https://doi.org/10.1016/j.vaccine.2006.08.026
- Bachmann, M.F., Zinkernagel, R.M., and Oxenius, A. (1998). Immune responses in the absence of costimulation: viruses know the trick. J. Immunol. 161, 5791-5794
- Barton, G.M., and Medzhitov, R. (2003). Toll-like receptor signaling pathways. Science 300, 1524-1525 https://doi.org/10.1126/science.1085536
- Bernasconi, N.L., Traggiai, E., and Lanzavecchia, A. (2002). Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202 https://doi.org/10.1126/science.1076071
- Bertolotti-Ciarlet, A., Ciarlet, M., Crawford, S.E., Conner, M.E., and Estes, M.K. (2003). Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 21, 3885-3900 https://doi.org/10.1016/S0264-410X(03)00308-6
- Beutler, B., Hoebe, K., Georgel, P., Tabeta, K., and Du, X. (2004). Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses. Microbes Infect. 6, 1374-1381 https://doi.org/10.1016/j.micinf.2004.08.017
- Blazevic, V., Trubey, C.M., and Shearer, G.M. (2000). Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum. Immunol. 61, 845-849 https://doi.org/10.1016/S0198-8859(00)00170-1
- Blink, E.J., Light, A., Kallies, A., Nutt, S.L., Hodgkin, P.D., and Tarlinton, D.M. (2005). Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J. Exp. Med. 201, 545-554 https://doi.org/10.1084/jem.20042060
- Bowie, A., and O'Neill, L.A. (2000). The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67, 508-514 https://doi.org/10.1002/jlb.67.4.508
- Bright, R.A., Carter, D.M., Crevar, C.J., Toapanta, F.R., Steckbeck, J.D., Cole, K.S., Kumar, N.M., Pushko, P., Smith, G., Tumpey, T.M., et al. (2008). Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 3, e1501 https://doi.org/10.1371/journal.pone.0001501
- Buonaguro, L., Tornesello, M.L., Tagliamonte, M., Gallo, R.C., Wang, L.X., Kamin-Lewis, R., Abdelwahab, S., Lewis, G.K., and Buonaguro, F.M. (2006). Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivoT-cell responses. J. Virol. 80, 9134-9143 https://doi.org/10.1128/JVI.00050-06
- Buonaguro, L., Monaco, A., Arico, E., Wang, E., Tornesello, M.L., Lewis, G.K., Marincola, F.M., and Buonaguro, F.M. (2008). Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics 9, S5 https://doi.org/10.1186/1471-2105-9-S2-S5
- Burrows, P.D., and Cooper, M.D. (1997). B cell development and differentiation. Curr. Opin. Immunol. 9, 239-244 https://doi.org/10.1016/S0952-7915(97)80142-2
- Cairns, B., Maile, R., Barnes, C.M., Frelinger, J.A., and Meyer, A.A. (2006). Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J. Trauma 61, 293-298; discussion 298-299 https://doi.org/10.1097/01.ta.0000228969.46633.bb
- Carter, R.H., and Fearon, D.T. (1992). CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107 https://doi.org/10.1126/science.1373518
- Carter, R.H., Spycher, M.O., Ng, Y.C., Hoffman, R., and Fearon, D.T. (1988). Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141, 457-463
- Chen, W., and Gluud, C. (2005). Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst. Rev.(4), CD000100 https://doi.org/10.1002/14651858.CD000100
- Chilosi, M., Adami, F., Lestani, M., Montagna, L., Cimarosto, L., Semenzato, G., Pizzolo, G., and Menestrina, F. (1999). CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod. Pathol. 12, 1101-1106
- Coutelier, J.P., van der Logt, J.T., Heessen, F.W., Warnier, G., and Van Snick, J. (1987). IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165, 64-69 https://doi.org/10.1084/jem.165.1.64
- Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., and Ahmed, R. (2003). Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969-4973 https://doi.org/10.4049/jimmunol.171.10.4969
- Crotty, S., Aubert, R.D., Glidewell, J., and Ahmed, R. (2004). Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286, 111-122 https://doi.org/10.1016/j.jim.2003.12.015
- de Lalla, F., Rinaldi, E., Santoro, D., and Pravettoni, G. (1988). Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study. Eur. J. Epidemiol. 4, 256-258 https://doi.org/10.1007/BF00144763
- Deml, L., Schirmbeck, R., Reimann, J., Wolf, H., and Wagner, R. (1997). Recombinant human immunodeficiency Pr55gag viruslike particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Virology 235, 26-39 https://doi.org/10.1006/viro.1997.8668
-
Deml, L., Speth, C., Dierich, M. P., Wolf, H., and Wagner, R. (2005). Recombinant HIV-1
$Pr55^{gag}$ virus-like particles: potent stimulators of innate and acquired immune responses. Mol. Immunol. 42, 259-277 https://doi.org/10.1016/j.molimm.2004.06.028 - den Dunnen, J., Gringhuis, S.I., and Geijtenbeek, T.B. (2008). Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol. Immunother. DOI 10.1007/s00262-008-0615-1
- Deng, L., Dai, P., Parikh, T., Cao, H., Bhoj, V., Sun, Q., Chen, Z., Merghoub, T., Houghton, A., and Shuman, S. (2008). Vaccinia virus subverts a mitochondrial antiviral signaling proteindependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3. J. Virol. 82, 10735-10746 https://doi.org/10.1128/JVI.01305-08
- Diebold, S.S. (2008). Recognition of viral single-stranded RNA by Toll-like receptors. Adv. Drug Deliv. Rev. 60, 813-823 https://doi.org/10.1016/j.addr.2007.11.004
- Dubois, B., Massacrier, C., and Caux, C. (2001). Selective attraction of naive and memory B cells by dendritic cells. J. Leukoc. Biol. 70, 633-641
- Fernandez-Sesma, A., Marukian, S., Ebersole, B.J., Kaminski, D., Park, M.S., Yuen, T., Sealfon, S.C., Garcia-Sastre, A., and Moran, T.M. (2006). Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304 https://doi.org/10.1128/JVI.02381-05
- Flehmig, B., Staedele, H., Xueref, C., Vidor, E., Zuckerman, J., and Zuckerman, A. (1997). Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine. J. Infect. 35, 37-40 https://doi.org/10.1016/S0163-4453(97)90929-4
- Galarza, J.M., Latham, T., and Cupo, A. (2005). Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol. 18, 244-251 https://doi.org/10.1089/vim.2005.18.244
- Gatto, D., Pfister, T., Jegerlehner, A., Martin, S.W., Kopf, M., and Bachmann, M.F. (2005). Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1. J. Exp. Med. 201, 993-1005 https://doi.org/10.1084/jem.20042239
- Gavin, A.L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., and Nemazee, D. (2006). Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314, 1936-1938 https://doi.org/10.1126/science.1135299
- Germain, R.N. (2004). An innately interesting decade of research in immunology. Nat. Med. 10, 1307-1320 https://doi.org/10.1038/nm1159
- Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J., and Madara, J.L. (2001). Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885 https://doi.org/10.4049/jimmunol.167.4.1882
- Grgacic, E.V., and Anderson, D.A. (2006). Virus-like particles: passport to immune recognition. Methods 40, 60-65 https://doi.org/10.1016/j.ymeth.2006.07.018
- Gururajan, M., Jacob, J., and Pulendran, B. (2007). Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS ONE 2, e863 https://doi.org/10.1371/journal.pone.0000863
- Gustavsson, S., Kinoshita, T., and Heyman, B. (1995). Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154, 6524-6528
- Hai, R., Martinez-Sobrido, L., Fraser, K.A., Ayllon, J., Garcia-Sastre, A., and Palese, P. (2008). Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J. Virol. 82, 10580-10590 https://doi.org/10.1128/JVI.01213-08
- Hebell, T., Ahearn, J.M., and Fearon, D.T. (1991). Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102-105 https://doi.org/10.1126/science.1718035
- Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 https://doi.org/10.1038/35047123
- Hoebe, K., Janssen, E., and Beutler, B. (2004). The interface between innate and adaptive immunity. Nat. Immunol. 5, 971-974 https://doi.org/10.1038/ni1004-971
- Honorati, M.C., Palareti, A., Dolzani, P., Busachi, C.A., Rizzoli, R., and Facchini, A. (1999). A mathematical model predicting antihepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin. Exp. Immunol. 116, 121-126 https://doi.org/10.1046/j.1365-2249.1999.00866.x
- Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H.J., Kopf, M., and Bachmann, M.F. (2007). TLR9 signaling in B cells determines class switch recombination to IgG2a. J. Immunol. 178, 2415-2420 https://doi.org/10.4049/jimmunol.178.4.2415
- Kaech, S.M., Wherry, E.J., and Ahmed, R. (2002). Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251-262 https://doi.org/10.1038/nri778
- Kalia, V., Sarkar, S., Gourley, T.S., Rouse, B.T., and Ahmed, R. (2006). Differentiation of memory B and T cells. Curr. Opin. Immunol. 18, 255-264 https://doi.org/10.1016/j.coi.2006.03.020
- Kang, S.M., Guo, L., Yao, Q., Skountzou, I., and Compans, R.W. (2004). Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J. Virol. 78, 9624-9632 https://doi.org/10.1128/JVI.78.18.9624-9632.2004
- Kawai, T., and Akira, S. (2007). TLR signaling. Semin. Immunol. 19, 24-32 https://doi.org/10.1016/j.smim.2006.12.004
- Kelsoe, G. (2000). Studies of the humoral immune response. Immunol. Res. 22, 199-210 https://doi.org/10.1385/IR:22:2-3:199
- Khanlou, H., Sanchez, S., Babaie, M., Chien, C., Hamwi, G., Ricaurte, J.C., Stein, T., Bhatti, L., Denouden, P., and Farthing, C. (2006). The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients. Arch. Intern. Med. 166, 1417 https://doi.org/10.1001/archinte.166.13.1417
- Klaus, G.G., Pepys, M.B., Kitajima, K., and Askonas, B.A. (1979). Activation of mouse complement by different classes of mouse antibody. Immunology 38, 687-695
-
Kopf, M., Abel, B., Gallimore, A., Carroll, M., and Bachmann, M.F. (2002). Complement component
$C_{3}$ promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8, 373-378 https://doi.org/10.1038/nm0402-373 - Koyama, S., Ishii, K.J., Kumar, H., Tanimoto, T., Coban, C., Uematsu, S., Kawai, T., and Akira, S. (2007). Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 179, 4711-4720 https://doi.org/10.4049/jimmunol.179.7.4711
- Kwissa, M., Kasturi, S.P., and Pulendran, B. (2007). The science of adjuvants. Expert Rev. Vaccines 6, 673-684 https://doi.org/10.1586/14760584.6.5.673
-
Le Goffic, R., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., and Si-Tahar, M. (2006). Detrimental contribution of the Toll-like receptor (TLR)
$_{3}$ to influenza A virus-induced acute pneumonia. PLoS Pathog 2, e53 https://doi.org/10.1371/journal.ppat.0020053 - Lee, H.K., Dunzendorfer, S., Soldau, K., and Tobias, P.S. (2006). Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24, 153-163 https://doi.org/10.1016/j.immuni.2005.12.012
- Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu,K., Bu, Z., and Chen, H. (2006). The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J. Virol. 80, 11115-11123 https://doi.org/10.1128/JVI.00993-06
- Lin, L., Gerth, A.J., and Peng, S.L. (2004). CpG DNA redirects class-switching towards 'Th1-like' Ig isotype production via TLR9 and MyD88. Eur. J. Immunol. 34, 1483-1487 https://doi.org/10.1002/eji.200324736
- Liu, N., Ohnishi, N., Ni, L., Akira, S., and Bacon, K.B. (2003). CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4, 687-693 https://doi.org/10.1038/ni941
- Lobue, A.D., Lindesmith, L., Yount, B., Harrington, P.R., Thompson, J.M., Johnston, R.E., Moe, C.L., and Baric, R.S. (2006). Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24, 5220-5234 https://doi.org/10.1016/j.vaccine.2006.03.080
- Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez- Sobrido, L., Akira, S., Gill, M.A., Garcia-Sastre, A., Katze, M.G., et al. (2008). Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335-345 https://doi.org/10.1128/JVI.01080-07
- Mansson, A., Adner, M., Hockerfelt, U., and Cardell, L.O. (2006). A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 118, 539-548
- Manz, R.A., Hauser, A.E., Hiepe, F., and Radbruch, A. (2005). Maintenance of serum antibody levels. Annu. Rev. Immunol. 23, 367-386 https://doi.org/10.1146/annurev.immunol.23.021704.115723
-
Markine-Goriaynoff, D., van der Logt, J.T., Truyens, C., Nguyen, T.D., Heessen, F.W., Bigaignon, G., Carlier, Y., and Coutelier, J.P. (2000). IFN-
$\gamma$ -independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12, 223-230 https://doi.org/10.1093/intimm/12.2.223 - Martin, M., Michalek, S.M., and Katz, J. (2003). Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect. Immun. 71, 2498-2507 https://doi.org/10.1128/IAI.71.5.2498-2507.2003
- McHeyzer-Williams, L.J., and McHeyzer-Williams, M.G. (2005). Antigen-specific memory B cell development. Annu. Rev. Immunol. 23, 487-513 https://doi.org/10.1146/annurev.immunol.23.021704.115732
- Meyer-Bahlburg, A., Khim, S., and Rawlings, D.J. (2007). B cellintrinsic TLR signals amplify but are not required for humoral immunity. J. Exp. Med. 204, 3095-3101 https://doi.org/10.1084/jem.20071250
- Minges Wols, H.A., Underhill, G.H., Kansas, G.S., and Witte, P.L. (2002). The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169, 4213-4221 https://doi.org/10.4049/jimmunol.169.8.4213
- Mortola, E., and Roy, P. (2004). Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett. 576, 174-178 https://doi.org/10.1016/j.febslet.2004.09.009
- Nemazee, D., Gavin, A., Hoebe, K., and Beutler, B. (2006). Immunology: Toll-like receptors and antibody responses. Nature 441, E4; discussion E4 https://doi.org/10.1038/nature04875
- Nimmerjahn, F., and Ravetch, J.V. (2005). Divergent immunoglobuling subclass activity through selective Fc receptor binding. Science 310, 1510-1512 https://doi.org/10.1126/science.1118948
- Ochsenbein, A.F., Pinschewer, D.D., Odermatt, B., Carroll, M.C., Hengartner, H., and Zinkernagel, R.M. (1999). Protective T cellindependent antiviral antibody responses are dependent on complement. J. Exp. Med. 190, 1165-1174 https://doi.org/10.1084/jem.190.8.1165
- Palese, P., Muster, T., Zheng, H., O'Neill, R., and Garcia-Sastre, A. (1999). Learning from our foes: a novel vaccine concept for influenza virus. Arch. Virol. Suppl. 15, 131-138
- Palucka, A.K., Laupeze, B., Aspord, C., Saito, H., Jego, G., Fay, J., Paczesny, S., Pascual, V., and Banchereau, J. (2005). Immunotherapy via dendritic cells. Adv. Exp. Med. Biol. 560, 105-114 https://doi.org/10.1007/0-387-24180-9_14
- Pasare, C., and Medzhitov, R. (2004). Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6, 1382-1387 https://doi.org/10.1016/j.micinf.2004.08.018
- Pasare, C., and Medzhitov, R. (2005). Control of B-cell responses by Toll-like receptors. Nature 438, 364-368 https://doi.org/10.1038/nature04267
- Pashine, A., Valiante, N.M., and Ulmer, J.B. (2005). Targeting the innate immune response with improved vaccine adjuvants. Nat. Med. 11, S63-68 https://doi.org/10.1038/nm1210
- Persing, D.H., Coler, R.N., Lacy, M.J., Johnson, D.A., Baldridge, J.R., Hershberg, R.M., and Reed, S.G. (2002). Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 10, S32-7 https://doi.org/10.1016/S0966-842X(02)02426-5
- Pichichero, M.E., Voloshen, T., and Passador, S. (1999). Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants. Pediatr. Infect. Dis. J. 18, 1106-1108 https://doi.org/10.1097/00006454-199912000-00019
- Plotkin, S.A. (2005). Vaccines: past, present and future. Nat. Med. 11, S5-11 https://doi.org/10.1038/nm1209
- Pulendran, B. (2004). Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199, 227-250 https://doi.org/10.1111/j.0105-2896.2004.00144.x
- Pulendran, B., and Ahmed, R. (2006). Translating innate immunity into immunological memory: implications for vaccine development. Cell 124, 849-863 https://doi.org/10.1016/j.cell.2006.02.019
- Pushko, P., Tumpey, T.M., Bu, F., Knell, J., Robinson, R., and Smith, G. (2005). Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23, 5751-5759 https://doi.org/10.1016/j.vaccine.2005.07.098
- Quan, F.S., Huang, C., Compans, R.W., and Kang, S.M. (2007a). Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 81, 3514-3524 https://doi.org/10.1128/JVI.02052-06
- Quan, F.S., Sailaja, G., Skountzou, I., Huang, C., Vzorov, A., Compans, R.W., and Kang, S.M. (2007b). Immunogenicity of viruslike particles containing modified human immunodeficiency virus envelope proteins. Vaccine 25, 3841-3850 https://doi.org/10.1016/j.vaccine.2007.01.107
- Quan, F.S., Compans, R.W., Nguyen, H.H., and Kang, S.M. (2008a). Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J. Virol. 82, 1350-1359 https://doi.org/10.1128/JVI.01615-07
- Quan, F.S., Steinhauer, D., Huang, C., Ross, T.M., Compans, R.W., and Kang, S.M. (2008b). A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 26, 3352-3361 https://doi.org/10.1016/j.vaccine.2008.03.055
- Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., and Pulendran, B. (2006). Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424 https://doi.org/10.1084/jem.20051720
- Rappuoli, R. (2004). From Pasteur to genomics: progress and challenges in infectious diseases. Nat. Med. 10, 1177-1185 https://doi.org/10.1038/nm1129
- Rappuoli, R. (2007). Bridging the knowledge gaps in vaccine design. Nat. Biotechnol. 25, 1361-1366 https://doi.org/10.1038/nbt1207-1361
- Reif, K., Ekland, E.H., Ohl, L., Nakano, H., Lipp, M., Forster, R., and Cyster, J.G. (2002). Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416, 94-99 https://doi.org/10.1038/416094a
- Ridderstad, A., and Tarlinton, D.M. (1998). Kinetics of establishing the memory B cell population as revealed by CD38 expression. J. Immunol. 160, 4688-4695
- Sailaja, G., Skountzou, I., Quan, F.S., Compans, R.W., and Kang, S.M. (2007). Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology 362, 331-341 https://doi.org/10.1016/j.virol.2006.12.014
- Sancho, D., Gomez, M., and Sanchez-Madrid, F. (2005). CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26, 136-140 https://doi.org/10.1016/j.it.2004.12.006
- Schnare, M., Barton, G.M., Holt, A.C., Takeda, K., Akira, S., and Medzhitov, R. (2001). Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950 https://doi.org/10.1038/ni712
- Shapiro-Shelef, M., and Calame, K. (2005). Regulation of plasmacell development. Nat. Rev. Immunol. 5, 230-242 https://doi.org/10.1038/nri1572
-
Shin, D., Yang, C.S., Lee, J.Y., Lee, S.J., Choi, H.H., Lee, H.M., Yuk, J.M., Harding, C.V., and Jo, E.K. (2008). Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C
$\zeta$ in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages. Cell Microbiol. 10, 1893-1905 https://doi.org/10.1111/j.1462-5822.2008.01179.x - Shinall, S.M., Gonzalez-Fernandez, M., Noelle, R.J., and Waldschmidt, T.J. (2000). Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164, 5729-5738 https://doi.org/10.4049/jimmunol.164.11.5729
- Sun, Y., Carrion, R., Jr., Ye, L., Wen, Z., Ro, Y.T., Brasky, K., Ticer, A.E., Schwegler, E.E., Patterson, J.L., Compans, R.W., et al. (2009). Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology 538, 12-21 https://doi.org/10.1016/j.virol.2008.09.020
- Takeda, K., and Akira, S. (2004). TLR signaling pathways. Semin. Immunol. 16, 3-9 https://doi.org/10.1016/j.smim.2003.10.003
- Takeshita, F., Kobiyama, K., Miyawaki, A., Jounai, N., and Okuda, K. (2008). The non-canonical role of Atg family members as suppressors of innate antiviral immune signaling. Autophagy 4, 67-69 https://doi.org/10.4161/auto.5055
- Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., Garcia-Sastre, A., and Palese, P. (2000). Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc. Natl. Acad. Sci. USA 97, 4309-4314 https://doi.org/10.1073/pnas.070525997
- Tiberio, L., Fletcher, L., Eldridge, J.H., and Duncan, D.D. (2004). Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A. Vaccine 22, 1515-1523 https://doi.org/10.1016/j.vaccine.2003.10.019
- Unterholzner, L., and Bowie, A.G. (2008). The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem. Pharmacol. 75, 589-602 https://doi.org/10.1016/j.bcp.2007.07.043
- Van Damme, P., Oosterhuis-Kafeja, F., Van der Wielen, M., Almagor, Y., Sharon, O., and Levin, Y. (2009). Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27, 454-459 https://doi.org/10.1016/j.vaccine.2008.10.077
- van der Sluijs, K.F., van Elden, L., Nijhuis, M., Schuurman, R., Florquin, S., Jansen, H.M., Lutter, R., and van der Poll, T. (2003). Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol. Lett. 89, 201-206 https://doi.org/10.1016/S0165-2478(03)00138-X
- van Duin, D., Medzhitov, R., and Shaw, A.C. (2006). Triggering TLR signaling in vaccination. Trends Immunol. 27, 49-55 https://doi.org/10.1016/j.it.2005.11.005
- Van Herck, K., Beutels, P., Van Damme, P., Beutels, M., Van den Dries, J., Briantais, P., and Vidor, E. (2000). Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. J. Med. Virol. 60, 1-7 https://doi.org/10.1002/(SICI)1096-9071(200001)60:1<1::AID-JMV1>3.0.CO;2-H
- Vinuesa, C.G., Tangye, S.G., Moser, B., and Mackay, C.R. (2005). Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5, 853-865 https://doi.org/10.1038/nri1714
- Warfield, K.L., Swenson, D.L., Demmin, G., and Bavari, S. (2005). Filovirus-like particles as vaccines and discovery tools. Expert Rev. Vaccines 4, 429-440 https://doi.org/10.1586/14760584.4.3.429
Cited by
- Systems biology applied to vaccine and immunotherapy development vol.5, pp.None, 2009, https://doi.org/10.1186/1752-0509-5-146
- Virus-like particles as universal influenza vaccines vol.11, pp.8, 2009, https://doi.org/10.1586/erv.12.70
- Protective efficacy of crude virus‐like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy vol.7, pp.3, 2013, https://doi.org/10.1111/j.1750-2659.2012.00396.x
- H9N2 avian influenza virus in Korea: evolution and vaccination vol.2, pp.1, 2009, https://doi.org/10.7774/cevr.2013.2.1.26
- Next-Generation Sequencing-Based Transcriptome Analysis of Helicoverpa armigera Larvae Immune-Primed with Photorhabdus luminescens TT01 vol.8, pp.11, 2009, https://doi.org/10.1371/journal.pone.0080146
- A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice vol.89, pp.15, 2009, https://doi.org/10.1128/jvi.00803-15
- Systemic and Mucosal B and T Cell Responses Upon Mucosal Vaccination of Teleost Fish vol.11, pp.None, 2021, https://doi.org/10.3389/fimmu.2020.622377
- CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.629102
- Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants vol.11, pp.None, 2021, https://doi.org/10.3389/fcimb.2021.745016
- Construction and Characterization of an Aeromonas hydrophila Multi-Gene Deletion Strain and Evaluation of Its Potential as a Live-Attenuated Vaccine in Grass Carp vol.9, pp.5, 2009, https://doi.org/10.3390/vaccines9050451
- Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions vol.9, pp.5, 2009, https://doi.org/10.3390/vaccines9050535
- Use of Protamine in Nanopharmaceuticals-A Review vol.11, pp.6, 2009, https://doi.org/10.3390/nano11061508